Navigant Life Sciences Leader Named Consulting Magazine “Rising Star”
March 13 2017 - 8:30AM
Business Wire
Elena Stavrakas Recognized for Leading Pharmaceutical
Partnerships that Positively Impact Product Launches, Brand
Optimization
Navigant (NYSE:NCI) today announced that Elena Stavrakas, a
director in the firm’s Healthcare Life Sciences practice, has been
recognized among the 2017 “Rising Stars of the Profession” by ALM’s
Consulting magazine. Stavrakas was selected from more than 200
nominees considered for the recognition, an annual list honoring 35
young up-and-comers in the consulting profession under the age of
35.
“The ‘Rising Stars of the Profession’ award isn’t just about
talent and potential, it’s about results and impact,” said
Consulting Editor & Publisher Joe Kornik. “These 35 winners are
difference makers to their firms, co-workers and their clients, but
they’re also moving the needle for the entire consulting
profession. And all before their 35th birthdays; it’s simply
amazing.”
Stavrakas, 33, specializes in biopharmaceutical strategic
commercial advisory with a particular focus on rare diseases,
commercial launch excellence, and business development strategy.
Since joining Navigant in 2008, she has overseen partnerships with
some of the industry’s leading pharmaceutical companies, supporting
delivery of complex disease area strategies, on-site brand planning
and execution, prioritization of acquisition opportunities, and
forecast model design and implementation.
“Elena has helped to build Navigant’s Life Sciences group into a
vibrant practice,” said David Zito, Navigant managing director and
healthcare segment leader. “Her ability to develop relationships
both internally and with key senior-level clients enables
Navigant’s Life Sciences practice to support a wide range of
successful initiatives, from pre-launch to post-launch.”
Stavrakas also co-leads Navigant Life Sciences’ new hire
training, helping to shape professionals for successful life
sciences careers. A graduate of Haverford College in Haverford,
Pa., she began her career in healthcare investment banking before
transitioning into consulting.
“I’m fortunate to be part of a team that collaborates with
biotech and pharmaceutical industry leadership to develop products
and services that impact people’s lives,” said Stavrakas. “It is
truly an honor to receive this recognition, which further validates
the exceptional value and partnership our team provides to our
clients.”
The “Rising Stars of the Profession” are recognized for
excellence in the following areas: leadership, client service,
strategy consulting, operations management consulting, healthcare,
financial services, high tech, retail, information technology, and
human resources.
This year’s honorees will be recognized by Consulting magazine
at a gala awards dinner at the W Chicago City Center on Thursday,
April 27.
Stavrakas’ full profile appears in the March 2017 issue of
Consulting magazine.
About Navigant
Navigant Consulting, Inc. (NYSE: NCI) is a specialized, global
professional services firm that helps clients take control of their
future. Navigant’s professionals apply deep industry knowledge,
substantive technical expertise, and an enterprising approach to
help clients build, manage, and/or protect their business
interests. With a focus on markets and clients facing
transformational change and significant regulatory or legal
pressures, the firm primarily serves clients in the healthcare,
energy, and financial services industries. Across a range of
advisory, consulting, outsourcing, and technology/analytics
services, Navigant’s practitioners bring sharp insight that
pinpoints opportunities and delivers powerful results. More
information about Navigant can be found at navigant.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170313005398/en/
Navigant Investor RelationsAaron
Miles312.583.5820aaron.miles@navigant.comorNavigant Corporate
CommunicationsBelia Ortega312.583.2640belia.ortega@navigant.com
Navigant Consulting (NYSE:NCI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Navigant Consulting (NYSE:NCI)
Historical Stock Chart
From Sep 2023 to Sep 2024